This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: CROX DKS HON HRB JNPR


TD Ameritrade (AMTD) downgraded to market perform at BMO Capital Markets based on valuation. The stock has outperformed its sector in 2013 thus far and now trades at notably higher multiples, BMO Capital Markets said.

Crocs (CROX - Get Report) was downgraded at Wedbush to neutral, because performance projections have been fully priced-in, Wedbush said. Although second-quarter results will likely be in line with management's guidance, the opportunity for near-term reward has contracted, Wedbush said.

Cognizant (CTSH) was upgraded at Goldman Sachs to buy. $90 price target. Immigration risk is fading and the company can deliver solid growth, Goldman said.

CVB Financial (CVBF) was downgraded at FIG Partners to market perform. Valuation call, based on a $14.50 price target, FIG Partners said.

Dick's Sporting Goods (DKS - Get Report) was upgraded at Morgan Stanley to overweight, based on enhanced fiscal 2014 estimates. DKS has underperformed the consumer discretionary sector despite strong fundamentals and trading at a discount, Morgan Stanley said.

Diamond Offshore (DO) was upgraded to buy at TheStreet Ratings.

Fairchild Semiconductor (FCS) was downgraded to hold at TheStreet Ratings.

Honeywell (HON - Get Report) was downgraded at Nomura to neutral. Valuation call, based on an $88 price target, Nomura said.

H&R Block (HRB - Get Report) was downgraded at BTIG to neutral from buy. Valuation call, as the stock exceeded the previous $31 price target, BTIG said.

Juniper (JNPR - Get Report) was downgraded at Jefferies to hold from buy. Valuation call, based on a $21.25 price target, Jefferies said.

Nokia (NOK) was downgraded at Oppenheimer to underperform from perform. Smartphone competition appears to be reaccelerating, Oppenheimer said.

North Star Realty (NRF) was initiated with a buy rating at UBS. $13 price target. The company will benefit as securitization markets and commercial loan demand improve, UBS said.

Onyx Pharmaceuticals (ONXX) was downgraded at Deutsche Bank to hold from buy. $140 price target. Company is likely to be acquired, but expect limited upside potential from current levels, Deutsche said.

Sonoco (SON) was upgraded at Bank of America/Merrill Lynch to buy from neutral. $42 price target. Several parts of the business appear to be turning around, BofA/Merrill said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CROX $11.93 1.02%
DKS $56.78 -0.37%
JNPR $22.50 -0.35%
HON $103.24 -1.03%
HRB $32.32 0.78%


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs